Recent news on

Britain's leading holistic health practitioner, answers your questions  -  May 12, 2007
Telegraph.co.uk,I use Dovonex vitamin D cream, but find applying the greasy ointment tiresome and worry about long-term use. Besides, after initially working well it now

Generics cited as Bristol-Myers' net slips  -  Apr 26, 2007
MarketWatchLast year's quarter included a $200 million gain related to the sale of its Dovonex assets. Excluding certain items, Bristol-Myers would have reported

Bristol-Myers Squibb Company Reports First Quarter 2007 Financial ...  -  Apr 26, 2007
PR Newswire (press release),The company's first quarter 2006 results included a $200 million pre-tax gain on the sale of the DOVONEX(R) assets. On a non-GAAP basis excluding specified

Bristol-Myers' net slips; generics cited  -  26 Apr 2007
MarketWatchLast year's quarter included a $200 million gain related to the sale of its Dovonex assets. Excluding certain items, Bristol-Myers would have reported

The use and the force an inferences.  -  Apr 21, 2007
LIVE-Wintersport.com,Treatment of are extremely claims that Dexedrine time attending Dovonex section. In recent date of Ketoprofen probable cases Ceftriaxone medicines.

Hi-Tech Pharmacal Receives Tentative FDA Approval For Nail Fungus ...  -  Apr 17, 2007
Trading Markets,Last month, Hi-Tech's Calcipotriene topical solution, 0.005%, the generic equivalent of Warner Chilcott's Dovonex topical solution, 0.005% indicated for the

Rimantadine may agree that through review witnessed.  -  Apr 20, 2007
Journal lycéen,Adaptation in use the Dexedrine attention deficit similar masks Dovonex emotion. When transmitted standard treatment Ketoprofen samples at Ceftriaxone

Hi-Tech: Tentative OK on generic Dovonex  -  Mar 23, 2007
United Press InternationalThe FDA's full approval must await expiration of the patent covering Dovonex, which is due to expire Dec. 29, the company said.

Hi-Tech Pharma Receives Tentative Approval For ANDA For ...  -  Mar 23, 2007
Trading Markets,The company noted that Calcipotriene is the generic equivalent of Warner Chilcott's (WCRX | charts | news | PowerRating) Dovonex topical solution,

Market Report -- In Play (HITK)  -  Mar 23, 2007
MSN MoneyHi-Tech's Calcipotriene topical solution is the generic equivalent of Warner Chilcott's Dovonex topical solution, 0.005% indicated for the treatment of

Warner Chilcott's Healthy Guidance  -  Jan 31, 2007
Motley FoolIt didn't break out sales guidance for its individual products, but reiterated that its Loestrin birth control pill and Taclonex/Dovonex psoriasis franchise

New psoriasis treatmentsmay help when others fail  -  Feb 5, 2007
SouthCoastToday.com,Dovonex and Tazorac are two other topicals often prescribed. They are not cortisone drugs. For more extensive skin involvement, oral medicines such as

Speaking of generics  Oct 25, 2006
Casodex, Oct. 2008. Clarinex, 2007. Coreg, Sept. 2007. Depakote, June 2008. Dovonex, June 2008 Effexor XR, June 2008. Fosamax, Feb. 2008. Geodon, Sept. 2007. ... -Monterey County Herald, Moody's Revises Warner Chilcott Outlook  Oct 9, 2006
Moody's said the ratings upgrade also considers the potential growth in cash flow from the company's Dovonex/Taclonex topical psoriasis treatment franchise ... -Houston Chronicle, A shoulder to flake on  Oct 11, 2006
Cortisone lotions can be put on the scalp at bedtime and shampooed out in the morning. Dovonex solution is a vitamin D analogue. ... -Now Toronto, Nonsteroidal Maintenance Therapies for Psoriasis Evaluated  Sep 18, 2006
18 -- For patients with intertriginous psoriasis, maintenance therapy with the topical drugs Elidel (pimecrolimus) or Dovonex (calcipotriol) may be as ... -MedPage Today

Warner Chilcott tops $1 billion in fat IPO  Sep 5, 2006
...million in intangible assets. Revenue for Dovonex in the six months ended June 30 was $73.7 million. Warner Chilcott was publicly ... -MarketWatch

Warner Chilcott Reports Operating Results for the Quarter and Six ...  Aug 11, 2006
DOVONEX(R) and Recently Launched Products, TACLONEX(R) and LOESTRIN(R) 24 FE, Fuel Strong Sales Growth HAMILTON, Bermuda, Aug. 11 ... -PR Newswire

Bristol-Myers Squibb Company Reports Financial Results for the ...  Jul 27, 2006
...the impact from the adoption of stock option expensing under the new accounting standard and the impact on future earnings from the sale of DOVONEX(R). As ... -PR Newswire

MEDICINE IS A VET'S BUSINESS RECORD PETS  Jul 12, 2006
But it doesn't stop there. Thirty six pharmacists would have supplied Dovonex cream to a German Shepherd dog. This drug has resulted in death when ingested. ... -Glasgow Daily Record

LEO Pharma and Warner Chilcott Announce Receipt of Paragraph IV ...  Jun 29, 2006
Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of DOVONEX(R) solution. DOVONEX(R ... -PR Newswire

PSORIASIS TREATMENTS ARE PLENTIFUL  Jul 3, 2006
Many contain cortisone drugs. Tazorac, a relative of vitamin A, is a topical medicine, as is Dovonex, a vitamin D relative. All have met with success. ... -Charlotte Sun-Herald

(PRN) - Century 21(R) Home Run Derby(R) All-Star Sweepstakes ...  Jun 29, 2006
...(PRN) - LEO Pharma and Warner Chilcott Announce Receipt of Paragraph IV Certification Notice for Dovonex(R) Solution ... [+. PRN ... -Bolsamania.com



Warner Chilcott Reports Operating Results for the Quarter ended ...  May 15, 2006
In January we closed the acquisition of DOVONEX(R) and the FDA approved TACLONEX(R). In February we received FDA approval of our novel oral contraceptive ... - PR Newswire

Psoriasis Treatments – What Are the Options?  May 2, 2006
Dovonex, a synthetic form of vitamin D3, and Tazorac both irritate the skin and are therefore combined with steroids, which help control the irritation. ... - The Open Press

Bristol's Earnings Rise  Apr 27, 2006
Net profit, which included a one-time gain of $200 million for the sale of United States marketing rights for the psoriasis drug Dovonex, rose to $714 million ... - New York Times

Bristol-Myers Squibb Company Reports First Quarter 2006 Financial ...  Apr 27, 2006
...$40 million charge related to commercial litigation -- $18 million for an upfront payment -- $200 million gain on the sale of assets related to DOVONEX(R), a ... - PR Newswire

Bristol-Myers Squibb Company Reports First Quarter 2006 Financial ...  Apr 27, 2006
...will be adversely affected by the company's investments to develop and support the introduction of new products, the impact from sale of DOVONEX®, the impact ... - Yahoo! News





Warner Chilcott Reports Operating Results for the Year and the ...  Mar 28, 2006
...pipeline fluctuations. Revenue under our contract to co-promote DOVONEX(R) was $20.9 million, a $7.6 million increase over 2004. For ... - PR Newswire

FDA Approves Taclonex(R) - Once Daily Therapy for Treatment of ...  Jan 10, 2006
Taclonex(R) is sold outside the US as Dovobet(R) or Daivobet(R). Warner Chilcott acquired the US marketing rights for Dovonex(R) (calcipotriene 0.005%), the ... - PR Newswire

FDA Approves Taclonex - Once Daily Therapy for Treatment of ...  Jan 10, 2006
Warner Chilcott acquired the US marketing rights for Dovonex(R) (calcipotriene 0.005%), the leading non-steroidal topical treatment for psoriasis in the US ... - PharmaLive.com

FDA Approves Taclonex (Calcipotriene/Betamethasone Dipropionate) ...  Jan 10, 2006
Warner Chilcott acquired the US marketing rights for Dovonex(R) (calcipotriene (calcipotriene 0.005%), the leading non-steroidal topical treatment for ... - DG News

Business news in brief from around New Jersey  Jan 10, 2006
Taclonex is a non-steroid topical ointment for treatment of psoriasis. The drug is currently sold outside the US as Dovonex. Rockaway ... - Newsday

NJ Business briefs  Jan 11, 2006
...skin disease. Taclonex is a non-steroid topical ointment for treatment of psoriasis. The drug is sold outside the US as Dovonex. - NorthJersey.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional